MAP2K7 and cancer: EGF and other EGF-like ligands trigger EGFR, which activates downstream pro-oncogenic signaling pathways, including the MAPK cascade (RAS-RAF-MEK-ERK) and PI3K-AKT-mTOR pathway, regulating cancer cell survival, growth and motility18.